Zou X - Search Results

1

Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.

Xiao L, Li Y, Hong C, Ma P, Zhu H, Cui H, Zou X, Wang J, Li R, He J, Liang S, Li Z, Zeng L, Liu L. Xiao L, et al. Among authors: zou x. J Transl Med. 2024 Jul 12;22(1):650. doi: 10.1186/s12967-024-05478-z. J Transl Med. 2024. PMID: 38997780 Free PMC article.

2

Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors.

Hong C, Dong HZ, Li RN, Zhu HB, Li QM, Cui H, Hu CY, Huang CY, Peng J, Liu L, Zou XJ, Xiao LS. Hong C, et al. Dig Dis. 2023;41(3):422-430. doi: 10.1159/000527574. Epub 2022 Oct 18. Dig Dis. 2023. PMID: 36257291

3

Radiomics signature based on CECT for non-invasive prediction of response to anti-PD-1 therapy in patients with hepatocellular carcinoma.

Cui H, Zeng L, Li R, Li Q, Hong C, Zhu H, Chen L, Liu L, Zou X, Xiao L. Cui H, et al. Among authors: zou x. Clin Radiol. 2023 Feb;78(2):e37-e44. doi: 10.1016/j.crad.2022.09.113. Epub 2022 Oct 17. Clin Radiol. 2023. PMID: 36257868

4

[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].

Xiao LS, Zou XJ, Hu W, Liu L. Xiao LS, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jun 20;36(7):974-8. Nan Fang Yi Ke Da Xue Xue Bao. 2016. PMID: 27435779 Chinese.

5

Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.

Wang K, Duan C, Zou X, Song Y, Li W, Xiao L, Peng J, Yao L, Long Q, Liu L. Wang K, et al. Among authors: zou x. Oncol Lett. 2018 Apr;15(4):4303-4313. doi: 10.3892/ol.2018.7820. Epub 2018 Jan 18. Oncol Lett. 2018. PMID: 29556287 Free PMC article.

6

The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.

Yao L, Zou X, Liu L. Yao L, et al. Among authors: zou x. Int J Clin Exp Pathol. 2019 Sep 1;12(9):3329-3343. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934176 Free PMC article.

7

[Ineffective platelet transfusion in patients with hematology malignancy].

Chen S, Xiao L, Zou X. Chen S, et al. Among authors: zou x. Zhonghua Yi Xue Za Zhi. 1998 Nov;78(11):824-6. Zhonghua Yi Xue Za Zhi. 1998. PMID: 11038776 Chinese.

8

Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.

Duan Z, Song Y, Zou X, Liu S, Zhang W, Liu L. Duan Z, et al. Among authors: zou x. Int J Clin Exp Pathol. 2020 May 1;13(5):972-978. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32509068 Free PMC article.

9

Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.

Liu S, Yu G, Liu L, Zou X, Zhou L, Hu E, Song Y. Liu S, et al. Among authors: zou x. Front Genet. 2021 Feb 11;12:625236. doi: 10.3389/fgene.2021.625236. eCollection 2021. Front Genet. 2021. PMID: 33643387 Free PMC article.

10

Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma.

Zhang DY, Zou XJ, Cao CH, Zhang T, Lei L, Qi XL, Liu L, Wu DH. Zhang DY, et al. Theranostics. 2018 Jun 13;8(14):3751-3765. doi: 10.7150/thno.22493. eCollection 2018. Theranostics. 2018. PMID: 30083257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,602 results

Search Page

Filters